PBM
NASDAQ HealthcarePsyence Biomedical Ltd. - Ordinary Shares
Biotechnology
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
🎯 投资策略评分
PBM 在各投资策略中的评分。分数越高，越符合该策略目标。
📚 了解更多
在文本中查找 PBM in your text
粘贴任何文章、记录或帖子 — 工具将提取 PBM 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-09-18.